FindTrial
Sign In

Understanding clinical aspects of Guillain Barre Syndrome

Study of Clinical profile, Prognostic factors, Treatment and Outcome in Guillain Barre Syndrome patients - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065303
Enrollment
50
Registered
2024-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G610- Guillain-Barre syndrome

Interventions

None listed

Sponsors

Dr Rahul Kurade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Guillain Barre Syndrome clinically in Sir T hospital aged = 13 years in a period of 8 months after getting permission from ethics committee, Bhavnagar

Exclusion criteria

Exclusion criteria: 1.HIV positive patients 2.Patients having electrolyte abnormality like persistent Hypokalemia 3.Transverse myelitis 4.Myasthenia Gravis

Design outcomes

Primary

MeasureTime frame
To assess clinical profile, prognostic factors, treatment and outcome in patients of Guillain Barre Syndrome Timepoint: 8 months—

Secondary

MeasureTime frame
1.Evaluation of demographic details of disease. 2.To assess factors influencing clinical outcome of the disease. 3.To assess disease progression and prognosis in Guillain Barre syndrome patients. Timepoint: 8 months—

Countries

India

Contacts

Public ContactDr Rahul Kurade

Government Medical College, Bhavnagar

ilahadiyel@gmail.com9825315890

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026